PCVX: Vaxcyte, Inc.
Performance
PCVX +62.14%
Watchlist
Select an item
Summary
PCVX at a glance
PCVX returned +62.14% over the past year and +21.62% a year over five years. Its worst drop in that year was -27.95%, smaller than 62% of stocks on Redstone, and its Sharpe ratio of 1.07 beats 78% of stocks on Redstone. It pays no dividends.
Current Drawdown
-8.52%
Rolling Volatility
55.15%
Actions
Metrics
Risk Indicators
Alpha47.47%
Beta1.25x
Sharpe1.07
Sortino1.92
Omega1.22
Calmar2.22
Martin5.36
Profile
About PCVX
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $10.6B
- Listed
- Jun 2020
- Employees
- 507
- Headquarters
- San Carlos, CA
- Website
- vaxcyte.com
Comparisons